Trial reportJAMA dermatology2013
Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study.
Trial report in JAMA dermatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00879944 (Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors), which is not on this map. Cited by 44 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Who cites it
44 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Body mass index, abdominal fatness, weight gain and the risk of psoriasis: a systematic review and dose-response meta-analysis of prospective studies.European journal of epidemiology · 2018Pooled it
- Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study.The British journal of dermatology · 2019Trial
- Pediatric Psoriasis: Comorbidities, Treatment Challenges and Unmet Needs.Dermatology and therapy · 2026Review
- Prevalence and Trends in Systemic Treatment for Pediatric Psoriasis in the USA between 2015 and 2021.Dermatology and therapy · 2025Article
- Global, regional and national disparities and temporal trends of common autoimmune disease burdens among children and adolescents from 1990 to 2019.BMJ global health · 2025Article
- Psoriasis in the paediatric population: assessment of comorbidities, risk factors of their occurrence, quality of life of patients and therapy implemented.Postepy dermatologii i alergologii · 2025Article
- Systemic Therapy of Psoriasis in Children-Proposal of an Algorithm for Interdisciplinary Teamwork.Journal of clinical medicine · 2024Article
- Nutritional Status in Pediatric Psoriasis: A Case-Control Study in a Tertiary Care Referral Centre.Children (Basel, Switzerland) · 2024Article
- Article
- Review
- Psoriasis and Cardiovascular Risk in Children: The Usefulness of Carotid Intima-Media Thickness.Pediatric cardiology · 2022Article
- Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review.Healthcare (Basel, Switzerland) · 2022Article
- Comorbid Psoriasis and Metabolic Syndrome: Clinical Implications and Optimal Management.Psoriasis (Auckland, N.Z.) · 2022Review
- Recommendations for Management of Childhood Psoriasis.Indian dermatology online journal · 2021Article
- Screening for Comorbid Cardiovascular Risk Factors in Pediatric Psoriasis Among Iraqi Patients: A Case-Control Study.Cureus · 2021Article
- Therapeutic challenges in managing pediatric psoriasis.International journal of women's dermatology · 2021Review
- Association of Metabolic Comorbidities with Pediatric Psoriasis: A Systematic Review and Meta-Analysis.Annals of dermatology · 2021Article
- Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis.Frontiers in pharmacology · 2021Review
- Mediterranean Diet as a Tool to Combat Inflammation and Chronic Diseases. An Overview.Biomedicines · 2020Review
- Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives.Psoriasis (Auckland, N.Z.) · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveTo investigate the relationship of excess and central adiposity with pediatric psoriasis severity. DESIGN, SETTING, AND
participantsMulticenter, cross-sectional study of 409 psoriatic children. Psoriasis was classified as mild (worst Physician's Global Assessment score ≤3 with body surface area ≤10%) or severe (worst Physician's Global Assessment score ≥3 with body surface area >10%). Children were enrolled from 9 countries between June 19, 2009, and December 2, 2011.
main outcome measuresExcess adiposity (body mass index percentile) and central adiposity (waist circumference percentile and waist to height ratio).
resultsExcess adiposity (body mass index ≥85th percentile) occurred in 37.9% of psoriatic children (n=155) vs 20.5% of controls (n=42) but did not differ significantly by severity. The odds ratio (95% CI) of obesity (body mass index ≥95th percentile) overall in psoriatic children vs controls was 4.29 (1.96-9.39) and was higher with severe (4.92; 2.20-10.99) than with mild (3.60; 1.56-8.30) psoriasis, particularly in the United States (7.60; 2.47-23.34, and 4.72; 1.43-15.56, respectively). Waist circumference above the 90th percentile occurred in 9.3% of the control (n=19), 14.0% of the mild psoriasis (n=27), and 21.2% of the of severe psoriasis (n=43) participants internationally; this incidence was highest in the United States (12.0% [n=13], 20.8% [16], and 31.1% [32], respectively). Waist to height ratio was significantly higher in psoriatic (0.48) vs control (0.46) children but was unaffected by psoriasis severity. Children with severe psoriasis at its worst, but mild at enrollment, showed no significant difference in excess or central adiposity from children whose psoriasis remained severe.
conclusionsGlobally, children with psoriasis have excess adiposity and increased central adiposity regardless of psoriasis severity. The increased metabolic risks associated with excess and central adiposity warrant early monitoring and lifestyle modification.
trial registrationclinicaltrials.gov Identifier: NCT00879944
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.